Home › Research › Vascular contributions
The role of inflammation in cerebral small vessel disease and vascular cognitive impairment, and therapeutic implications
Robin Brown, Stuart McRae Allan, Hugh Stephen Markus. International Journal of Stroke, 2026-06-08
Topic: Brain proteins, microglia and lab models
Plain-language summary
Considerable data support the presence of both systemic and CNS inflammation in SVD and VCID. However, whether these associations are causal remains unclear, and more longitudinal and interventional studies are required. A better understanding of the molecular basis of inflammation and immune dysfunction in SVD also allows more precise therapeutic targeting.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. This review states that inflammation is present in cerebral small vessel disease and vascular cognitive impairment, but whether it causes these conditions is unclear. It calls for more longitudinal and interventional studies, so no treatment or prevention is established.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Brown, R., Allan, S. M., & Markus, H. S. (2026). The role of inflammation in cerebral small vessel disease and vascular cognitive impairment, and therapeutic implications. International Journal of Stroke. https://doi.org/10.1177/17474930261461366
Vancouver
Brown R, Allan SM, Markus HS. The role of inflammation in cerebral small vessel disease and vascular cognitive impairment, and therapeutic implications. International Journal of Stroke. 2026. doi:10.1177/17474930261461366. PMID: 42257423.
BibTeX
@article{brown2026-42257423,
author = {Brown, Robin and Allan, Stuart McRae and Markus, Hugh Stephen},
title = {{The role of inflammation in cerebral small vessel disease and vascular cognitive impairment, and therapeutic implications}},
journal = {International Journal of Stroke},
year = {2026},
doi = {10.1177/17474930261461366},
pmid = {42257423},
url = {https://doi.org/10.1177/17474930261461366}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Considerable data support the presence of both systemic and CNS inflammation in SVD and VCID.
- However, whether these associations are causal remains unclear, and more longitudinal and interventional studies are required.
- A better understanding of the molecular basis of inflammation and immune dysfunction in SVD also allows more precise therapeutic targeting.
Why it matters
This review states that inflammation is present in cerebral small vessel disease and vascular cognitive impairment, but whether it causes these conditions is unclear. It calls for more longitudinal and interventional studies, so no treatment or prevention is established.
Study details
- Study designlongitudinal study
- Evidence strengthModerate
How this study scored 51/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (International Journal of Stroke) |
| Journal's citation record | 1 / 4 | International Journal of Stroke: journal h-index 133 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 3 / 6 | Cited 7.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Hugh Stephen Markus: h-index 137 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Cambridge: institution h-index 1,973 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42257423) |
| Free to read | 2 / 2 | Free to read |
| Total | 51 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1177/17474930261461366
- PubMed: 42257423
- Original source →
- Free full text: International Journal of Stroke →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 19.
Related studies in Vascular contributions from nearby years
Also tagged “small”
900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.